Results 171 to 180 of about 68,976 (225)
Some of the next articles are maybe not open access.
Organ Visualisation with Technetium 99m Preparations
The British Journal of Radiology, 1967Abstract Selected examples are presented in this paper to illustrate the potentialities of the use of some of the 99mTc compounds for organ visualisation. Although no attempt has been made at clinical evaluation, the additional information which can be gained by this means is both useful and impressive to those familiar with the technique.
I, Kazem, P, Gelinsky, P, Schenck
openaire +2 more sources
Noncardiac uptake of technetium-99m MIBI
Seminars in Nuclear Medicine, 1994A 74-YEAR-OLD spanish-speaking Peruvian woman underwent total thyroidectomy with bilateral median neck dissection in 1977 for follicular thyroid carcinoma. This was followed by Iodine-131 (1311) ablation for remnant thyroid tissue. In 1987, a 131I whole-body scan and a computed tomography scan of the chest confirmed lung metastasis as well as ...
C W, Sutter, M J, Joshi, R C, Stadalnik
openaire +2 more sources
Sub-Millimeter Technetium-99m Calibration Sources
Molecular Imaging & Biology, 2002Small animal radioscintigraphic imaging systems aim to achieve sub-millimeter resolution. At the present time, sub-millimeter calibration sources that can be placed at will within an imaged volume are not readily available. We have developed a method for producing technetium-99m (Tc-99m) sources in less than 15 minutes with readily available reagents ...
Jeffrey R, English +6 more
openaire +2 more sources
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1998
Scintigraphic techniques are routinely used for the evaluation of the extent and severity of inflammatory bowel disease. Currently, the radiopharmaceutical of choice is 99mTc-hexamethyl propyleneamine oxime (HMPAO)-leukocytes. We studied the imaging potential of two recently developed 99mTc-labeled agents, polyethylene glycol (PEG)-coated liposomes and
Dams, E.T.M. +7 more
openaire +3 more sources
Scintigraphic techniques are routinely used for the evaluation of the extent and severity of inflammatory bowel disease. Currently, the radiopharmaceutical of choice is 99mTc-hexamethyl propyleneamine oxime (HMPAO)-leukocytes. We studied the imaging potential of two recently developed 99mTc-labeled agents, polyethylene glycol (PEG)-coated liposomes and
Dams, E.T.M. +7 more
openaire +3 more sources
Technetium-99m-human fibrinogen.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1976Exogenous fibrinogen has been successfully labeled with 99mTc using a modified electrolytic method. The exact labeling mechanism has not been determined. Experimental data suggest that the labeling process of 99mTc-fibrinogen is quite similar to that of 99mTc-human serum albumin as reported earlier by Benjamin.
D W, Wong, F S, Mishkin
openaire +1 more source
Addressing Technetium-99m Shortage
Journal of the American College of Radiology, 2017Mahadevappa Mahesh, Mark Madsen
openaire +2 more sources
Technetium-99m Diphosphonate Retention in Hyperparathyroidism
Annals of Internal Medicine, 1980Excerpt To the editor: Fogelman and colleagues (1) show increased total-body retention of technetium-99m diphosphonate in a small group of patients with primary hyperparathyroidism and equate this ...
openaire +2 more sources
Clinical experience with technetium 99m teboroxime
Seminars in Nuclear Medicine, 1991Technetium 99m teboroxime is a boronic acid adduct of technetium dioxime complex, a neutral lipophilic technetium-containing myocardial perfusion imaging agent with high myocardial extraction, rapid myocardial washout, and entero-hepatic excretion. Early "redistribution" occurs, and, based on preliminary animal data, appears to be due to differential ...
openaire +2 more sources
The Radiopharmaceutical Chemistry of Technetium-99m
Radiopharmaceutical Chemistry, 2019S. Rathmann +5 more
semanticscholar +1 more source
Newer Technetium-99m Radiopharmaceuticals
1987Just now, we are having the semicentenary of the discovery of the element 43, later on named “technetium” (1,2). In 1937, Perrier and Segre showed that radioactive isotopes of element 43 could be formed by neutron or deuteron bombardment of molybdenum. They investigated the activity in order to collect some information on the chemistry of 43.
openaire +1 more source

